Recordati reported EUR341.55M in Cash and Equivalent for its fiscal quarter ending in June of 2025.


Cash And Equivalent Change Date
Almirall EUR 374.4M 2.7M Mar/2025
GlaxoSmithKline GBP 3.6B 865M Jun/2025
Hikma Pharmaceutical USD 188M 188M Dec/2024
Orion EUR 259.4M 53.8M Mar/2025
Sanofi 15.36B 7.37B Jun/2025